Newsletters

Newsletters

JETEMA participated at 2023 InterCHARM Korea

VOL. 12 JETEMA participated at 2023 InterCHARM Korea

JETEMA’s Pick for the Advertisement Model of e-p-t-q

VOL. 11 JETEMA’s Pick for the Advertisement Model of e.p.t.q.®

JETEMA successfully holds the 2023 JETEMA Symposium

VOL. 10 JETEMA successfully holds the 2023 JETEMA Symposium

JETEMA successfully held the 4th Jetema Academic Meeting (JAM)

VOL. 09 JETEMA successfully held the 4th Jetema Academic Meeting (JAM)

JETEMA successfully held the JETEMA Masterclass at IMCAS World Congress 2022

VOL. 08 JETEMA successfully held the JETEMA Masterclass at IMCAS World Congress 2022

JETEMA successfully held the 3rd Jetema Academic Meeting (JAM)

VOL. 07 JETEMA successfully held the 3rd Jetema Academic Meeting (JAM)

JETEMA successfully held the 2nd Jetema Academic Meeting (JAM)

VOL. 06 JETEMA successfully held the 2nd Jetema Academic Meeting (JAM)

Jetema successfully held IMCAS ACADEMY Online Symposium

VOL. 05 Jetema successfully held IMCAS ACADEMY Online Symposium

Jetema successfully held the 1st Jetema Academic Meeting(JAM)

VOL. 04 Jetema successfully held the 1st Jetema Academic Meeting(JAM)

THE TOXIN, to benchmark Faewoong, who first received the U.S

VOL. 03 THE TOXIN, to benchmark Faewoong, who first received the U.S.FDA approval for b.toxin

Jetema plans to sail through partnering with Huadong Ningbo Medicine, China

VOL. 02 Jetema plans to sail through partnering with Huadong Ningbo Medicine, China

Jetema steps up as a global aesthetic leader with 'THE TOXIN' botulinum toxin tyoe A in July 2020

VOL. 01 Jetema steps up as a global aesthetic leader with 'THE TOXIN', botulinum toxin tyoe A in July 2020

Get in Touch